Clinical Trials Browser

Recurrence × Irinotecan × Breast × Clear all

NCT02030678 2018-09-05

A Phase II Study of Irinotecan in 3 Line or More Therapy in Local Recurrence or Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms, Recurrence